The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

CITIC 21CN Funding, CITIC 21CN Valuation & CITIC 21CN Revenue

5 Fundings

CITIC 21CN's latest funding round was a Corporate Majority - P2P for $170M on January 23, 2014.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

1/23/2014

Corporate Majority - P2P

$170M

0

FY undefined

2

1/1/2004

Corporate Minority - P2P - III

0

FY undefined

10

1/1/2000

Corporate Minority - P2P - II

0

FY undefined

10

1/1/1997

Corporate Minority - P2P

0

FY undefined

0

7/6/1972

IPO

0

FY undefined

0

Date

1/23/2014

1/1/2004

1/1/2000

1/1/1997

7/6/1972

Round

Corporate Majority - P2P

Corporate Minority - P2P - III

Corporate Minority - P2P - II

Corporate Minority - P2P

IPO

Amount

$170M

Investors

Valuation

Revenue

0

FY undefined

0

FY undefined

0

FY undefined

0

FY undefined

0

FY undefined

Sources

2

10

10

0

0

CITIC 21CN Acquisitions

1 Acquisition

CITIC 21CN acquired 1 company. Their latest acquisition was Alibaba Health on October 21, 2014.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

10/21/2014

$99M

Reverse Merger

3

Date

10/21/2014

Investment Stage

Companies

Valuation

$99M

Total Funding

Note

Reverse Merger

Sources

3

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.